Hepion Regulatory Monday, September 28, 2026 0.00 Neutral

Grassi & Co. agrees to financial statements in Hepion's Form 8-K.

Hepion Pharmaceuticals reported in its Form 8-K that independent auditors Grassi & Co. have agreed with the financial statements contained in the filing. This confirmation provides closure on the company's recent disclosure.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed